Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) FCF Margin: 2019-2025

Historic FCF Margin for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -41.01%.

  • Biodesix's FCF Margin rose 1905.00% to -41.01% in Q3 2025 from the same period last year, while for Sep 2025 it was -36.37%, marking a year-over-year increase of 5852.00%. This contributed to the annual value of -72.74% for FY2024, which is 2054.00% up from last year.
  • Per Biodesix's latest filing, its FCF Margin stood at -41.01% for Q3 2025, which was down 24.03% from -33.07% recorded in Q2 2025.
  • Biodesix's FCF Margin's 5-year high stood at 6.81% during Q2 2021, with a 5-year trough of -204.05% in Q1 2022.
  • Moreover, its 3-year median value for FCF Margin was -60.06% (2024), whereas its average is -74.32%.
  • In the last 5 years, Biodesix's FCF Margin skyrocketed by 11,148bps in 2021 and then crashed by 16,320bps in 2022.
  • Quarterly analysis of 5 years shows Biodesix's FCF Margin stood at -148.49% in 2021, then spiked by 403bps to -144.46% in 2022, then soared by 4,037bps to -104.08% in 2023, then spiked by 7,993bps to -24.16% in 2024, then spiked by 1,905bps to -41.01% in 2025.
  • Its FCF Margin stands at -41.01% for Q3 2025, versus -33.07% for Q2 2025 and -48.31% for Q1 2025.